A UK maker of cannabis-based treatment is starting construction on a 60,000 sq ft factory in Kent. Jazz Pharmaceuticals, which bought GW Pharmaceuticals last year for $7.2bn, is spending £100m on the facility at its existing site at Kent Science
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
Register
Find Out More